NEUROSTHENOL, oral solution 20 ampoules of 5 ml
Active ingredients: ACIDE GLUTAMIQUE, ACIDE PHOSPHORIQUE CONCENTRÉ, CHLORURE DE MAGNÉSIUM HEXAHYDRATÉ, Manganese chloride tetrahydrate, Monohydratemonobasiccalcium phosphate, Dihydratemonobasicsodium phosphate
Commercialized according to BDPM
Oral solution20 ampoules of 5 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NEUROSTHENOL, solution buvable
- Pharmaceutical form
- solution buvable
- Route of administration
- orale
- Presentation description
- 20 ampoule(s) en verre brun de 5 ml
- Marketing authorisation holder
- RICHARD
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 6 May 2011
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66383389CIP73071934CIP133400930719343Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PHOSPHATE MONOCALCIQUE MONOHYDRATÉsolution | 0,200 g · 1 ampoule de 5 ml | SA |
| ACIDE GLUTAMIQUEsolution | 0,150 g · 1 ampoule de 5 ml | SA |
| CHLORURE DE MAGNÉSIUM HEXAHYDRATÉsolution | 0,250 g · 1 ampoule de 5 ml | SA |
| ACIDE PHOSPHORIQUE CONCENTRÉsolution | 0,560 g · 1 ampoule de 5 ml | SA |
| MANGANÈSE (CHLORURE DE)solution | 0,010 g · 1 ampoule de 5 ml | SA |
| SODIUM (DIHYDROGÉNOPHOSPHATE DE) DIHYDRATÉsolution | 0,100 g · 1 ampoule de 5 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.